Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Bioscience crawled time : 00:00 save search
Satellos Bioscience Announces 2023 Year End Financial Results and Operational Highlights
Published: 2024-03-27 (Crawled : 00:00) - biospace.com/
MSCLF | $0.3717 18.14% 15K
|
n/a
|
| O: 2.7%
H: 1.41%
C: 0.0%
year bioscience financial results
PURE Bioscience Reports Fiscal Second Quarter 2024 Financial Results
Published: 2024-03-18 (Crawled : 00:00) - biospace.com/
PURE | $0.08 1.01% 14K
|
Manufacturing
|
| O: 0.0%
H: 0.0%
C: -2.22%
bioscience financial results
Twist Bioscience to Report Fiscal 2023 Fourth Quarter and Full Year Financial Results on Friday, November 17, 2023
Published: 2023-11-02 (Crawled : 00:00) - biospace.com/
TWST | $29.23 -4.73% -4.96% 860K
|
Health Technology
|
| O: 3.97%
H: 7.94%
C: 6.59%
report year bioscience financial results
Aadi Bioscience Announces Multiple Presentations on nab-Sirolimus at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2023-04-26 (Crawled : 00:00) - biospace.com/
AADI | $1.91 -2.55% -2.62% 170K
|
Manufacturing
|
| O: 0.0%
H: 2.11%
C: 0.13%
bioscience meeting
Daré Bioscience to Present at the Maxim 2022 Virtual Growth Conference
Published: 2022-03-22 (Crawled : 00:00) - biospace.com/
DARE | $0.48 2.26% 2.21% 200K
|
Health Technology
|
| O: -1.27%
H: 2.58%
C: 1.94%
conference bioscience growth
Neurocrine Biosciences to Present at Stifel 2022 CNS Days
Published: 2022-03-21 (Crawled : 00:00) - biospace.com/
NBIX | $131.68 -2.21% -2.26% 770K
|
Health Technology
|
| O: -0.03%
H: 1.33%
C: 1.14%
bioscience
Liminal BioSciences Reports Fourth Quarter and Year End 2021 Financial Results
Published: 2022-03-17 (Crawled : 00:00) - prnewswire.com
LMNL | $8.5 0.12% 0.12% 0
|
Health Technology
|
| O: -0.36%
H: 4.42%
C: 2.48%
financial results report bioscience results
PhenoVista Biosciences Announces Michelle Mack as VP of Business Development
Published: 2022-03-03 (Crawled : 00:00) - biospace.com/
CSBR | $5.16 3.2% 3.1% 190
|
Health Technology
|
| O: 3.62%
H: 0.0%
C: 0.0%
pheno bioscience
Neurocrine Biosciences Provides Preliminary Fourth Quarter and Full-Year 2021 Net Product Sales Results and Future Program Milestones
Published: 2022-01-06 (Crawled : 00:00) - biospace.com/
PPRUF | $372.308 37.56% 3.1K
|
Consumer Non-Durables
|
| O: 2.64%
H: 0.0%
C: -0.39%
PPRUY | $37.06 -0.11% 120K
|
Manufacturing
|
| O: -0.99%
H: 0.0%
C: -1.16%
TAK | $13.18 -1.42% 0.0% 1.8M
|
Health Technology
|
| O: 1.0%
H: 0.0%
C: 0.0%
NBIX | $131.68 -2.21% -2.26% 770K
|
Health Technology
|
| O: 0.24%
H: 0.0%
C: 0.0%
sales bioscience milestone
Assembly Biosciences Outlines Anticipated 2022 Pipeline Development Milestones
Published: 2022-01-04 (Crawled : 00:00) - biospace.com/
ASMB | $14.91 1.78% 1.74% 17K
|
Health Technology
|
| O: -1.63%
H: 0.0%
C: 0.0%
bioscience milestone
Neurocrine Biosciences Announces Positive Phase 3 Data for KINECT-HD Study Evaluating Valbenazine for Chorea Associated with Huntington Disease
Published: 2021-12-07 (Crawled : 00:00) - biospace.com/
NBIX | $131.68 -2.21% -2.26% 770K
|
Health Technology
|
| O: 0.61%
H: 0.0%
C: 0.0%
huntington disease positive bioscience phase 3 huntington’s disease
Precision BioSciences to Host Virtual Webcast and Conference Call to Review Interim Phase 1/2a PBCAR0191 CAR T Data and Provide CAR T Program Updates on Saturday, December 11, 2021
Published: 2021-12-06 (Crawled : 00:00) - biospace.com/
DTIL | $13.02 -7.79% -8.45% 110K
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: 0.0%
conference phase 1 bioscience
Junshi Biosciences Announces FDA Expanded Emergency Use Authorization for Etesevimab and Bamlanivimab Administered Together to Include Individuals under the Age of 12
Published: 2021-12-05 (Crawled : 00:00) - globenewswire.com
LLY | $750.77 -0.12% 0.0% 2.3M
|
Health Technology
|
| O: -2.2%
H: 0.0%
C: 0.0%
fda authorization bioscience merge emergency use authorization
Bruker BioSciences Set to Join S&P MidCap 400; Others to Join S&P SmallCap 600
Published: 2021-11-24 (Crawled : 00:00) - prnewswire.com
CARS | $16.08 -2.9% 0.0% 290K
|
Technology Services
| Email alert
Add to watchlist
KAR | $17.45 -0.17% 0.0% 740K
|
Commercial Services
| Email alert
Add to watchlist
CNHI | $12.7 0.55% 0.0% 7.5M
|
Producer Manufacturing
| Email alert
Add to watchlist
SPGI | $409.56 -1.98% 0.0% 1M
|
Commercial Services
| Email alert
Add to watchlist
set bioscience
Junshi Biosciences Announces 2021 Interim Financial Results and Provides Corporate Updates
Published: 2021-08-30 (Crawled : 00:00) - globenewswire.com
LLY | $750.77 -0.12% 0.0% 2.3M
|
Health Technology
|
| O: 0.2%
H: 0.3%
C: -1.73%
CHRS | $2.22 -0.45% -0.45% 2.2M
|
Health Technology
|
| O: -0.25%
H: 1.33%
C: 1.14%
financial results results bioscience
Aadi Bioscience Announces Closing of Merger with Aerpio Pharmaceuticals and $155M Private Placement
Published: 2021-08-26 (Crawled : 00:00) - globenewswire.com
JNJ | $147.59 0.05% 0.0% 8.5M
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: 0.0%
GILD | $67.76 -1.3% -1.31% 7.7M
|
Health Technology
|
| O: -0.17%
H: 1.6%
C: -0.04%
FBIO | $1.81 -0.55% -0.55% 340K
|
Health Technology
|
| O: 0.65%
H: 5.79%
C: 4.5%
merge bioscience
Pulse Biosciences Announces Appointment of Mitchell E. Levinson as Chief Strategy Officer
Published: 2021-08-19 (Crawled : 00:00) - biospace.com/
PLSE | $7.83 8.45% 7.79% 330K
|
Health Technology
|
| O: -0.97%
H: 0.47%
C: -1.77%
bioscience
Solid Biosciences Strengthens Management Team to Advance Programs for Duchenne Muscular Dystrophy
Published: 2021-07-01 (Crawled : 00:00) - biospace.com/
SLDB | $9.99 -3.66% -3.8% 150K
|
Health Technology
|
| O: -0.27%
H: 3.29%
C: 3.29%
duchenne bioscience
Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2021 Financial Results
Published: 2021-04-14 (Crawled : 00:00) - biospace.com/
NBIX | $131.68 -2.21% -2.26% 770K
|
Health Technology
|
| O: 0.32%
H: 3.99%
C: 1.91%
financial results results conference bioscience
INVO Bioscience Expands Company-Owned Clinic Opportunity Under Amended U.S. Commercialization Agreement
Published: 2021-03-08 (Crawled : 00:00) - biospace.com/
INVO | $0.761 -6.63% -7.1% 24K
|
Health Technology
|
| O: -3.25%
H: 6.73%
C: -4.89%
commercialization bioscience
Gainers vs Losers
| 49% | 51% |
Top 10 Gainers
KAVL | $6.275 135.02% 57.45% 44M
|
Wholesale Trade
PXMD | $0.7375 79.09% 44.16% 4.5M
|
Health Technology
DYNT | $0.371 -5.12% 43.09% 3.3M
|
Health Technology
LGVN P 3 d | $2.94 73.96% 42.52% 57M
|
HUBC | $1.94 49.23% 32.99% 73M
|
n/a
SPCB | $0.4044 46.52% 31.75% 130M
|
Electronic Technology
ONVO | $1.34 32.66% 24.62% 54M
|
Health Technology
OMQS | $0.6869 32.1% 24.3% 3.6M
|
Professional, Scientific, and T...
SNPO | $10.555 29.67% 22.88% 4M
|
AMBI | $3.72 -26.77% 21.77% 9.8K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.